HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Merkel Cell Cancer

Merkel Cell Cancer

Merkel Cell Carcinoma (MCC) is an uncommon but highly malignant skin cancer originating from Merkel cells in the epidermis. Strongly associated with the Merkel cell polyomavirus (MCPyV), present in around 80% of cases, MCC typically affects older adults and those with compromised immune systems. Recent strides in cancer research have led to promising immunotherapies, including checkpoint inhibitors, which enhance the immune system's ability to identify and eradicate cancer cells. Early diagnosis is critical due to MCC's propensity for rapid metastasis, complicating treatment. Research efforts continue to focus on unraveling the molecular underpinnings of MCC, with the goal of developing more effective therapeutic strategies and improving patient survival rates.

Committee Members
Committee Member - Michael Thompson

Michael Thompson

University of Toronto, Canada
Committee Member - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States

Submit your abstract Today

YouTube
WhatsAppWhatsApp